Mindray MC-80 Morphological Diagnosis Service System
Morphological diagnostic system
Untreated acute leukemia has a very high mortality rate, with most patients dying within three to four months of onset. Thanks to MC-80's diagnostic and information systems, an entirely automated diagnostic process boosts the pace of tumor cell screening by more than three times, allowing patients to receive treatment faster and enjoy a cure rate of over 90%. It also enables cross-regional access to top specialists by integrating and radiating cross-institutional information flow and a growing database. Leukemia patients in underserved areas now have equitable access to testing services with the high-value, affordable MC-80.
Client / Manufacturer
Design
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Shenzhen, CNShenzhen Mindray Bio-Medical Electronics Co., Ltd.
Shenzhen, CNDate of Launch
2021
Development Time
25 - 36 months
Target Regions
Africa, Asia, Australia / Oceania, Europe, North America, South America
Target Groups
Specific sub-group: Medical Staff